3//SEC Filing
B Group, Inc. 3
Accession 0001213900-25-079145
CIK 0001719406other
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 6:21 AM ET
Size
5.1 KB
Accession
0001213900-25-079145
Insider Transaction Report
Form 3
B Group, Inc.
10% Owner
Holdings
- 3,000,000(indirect: See Note 1)
Common Stock
Footnotes (1)
- [F1]The reporting persons are The B Group, Inc. ("B Group"), B Group Capital LLC (the "Fund") and Branden B. Muhl. B Group is the investment adviser of the Fund. Mr. Muhl is the manager and controlling owner of the Fund and B Group, respectively. B Group is filing this Form 3 for itself, the Fund and Mr. Muhl. The securities are held directly by the Fund. The reporting persons are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 3d-5(b) under the Securities Exchange Act of 1934, as amended. B Group may be deemed to indirectly beneficially own the securities as the investment adviser to the Fund. Mr. Muhl may be deemed to indirectly beneficially own securities as the manager of the Fund and control person of B Group. The reporting persons disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
IncorporatedKS
Related Parties
1- filerCIK 0002043476
Filing Metadata
- Form type
- 3
- Filed
- Aug 20, 8:00 PM ET
- Accepted
- Aug 21, 6:21 AM ET
- Size
- 5.1 KB